Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Morgan Stanley analyst Terence Flynn notes that Novo Nordisk (NVO) reported CagriSema Phase 3 data in type two diabetes demonstrating weight ...

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

Judy Kurtz chats with The Hill’s congressional reporter Mychael Schnell about President Trump saying he wants to “help” Mexico and Canada with his delay of some tariffs against Canada and Mexico until ...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...

Global Active Pharmaceutical Ingredients Market is valued at USD 155.2 Billion in 2023. Global Active Pharmaceutical Ingredients Market valuation to reach USD 314.24 Billion by 2032. Active ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. Let's figure out ...

It was FDA approved based on a clinical trial that showed it, overall, delayed the onset of insulin dependence from two years ...

Lexaria executing a triple-pronged strategy in obesity and diabetesSemaglutide recently approved to treat chronic kidney disease KELOWNA, BC / ACCESS Newswire / February 27, 2025 / Lexaria Bioscience ...

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

The fourth single lifted from the band's self-titled debut album Five, Everybody Get Up comes in at Number 3 on the lift; shifting a total of 465,000 chart units to date. At the time, it earned ...